Name: Gemma Frisius Fund - BioCentury Company Profiles - BCIQ
Creator: Biocentury

signInButton

SIGN IN

Find partnering and investment opportunities, uncover and track competitive threats, dive into a company's financing and deal history, its pipeline and molecular targets of interest, and much more. Please note, you are viewing a free version of BCIQ, BioCentury's advanced business intelligence database for the biopharma industry. Request a trial to unlock the full value of BCIQ.

REQUEST A FREE TRIAL

AcquiredOrMerged

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.

If you believe a company has been archived in error, please contact us at 

Company profiles have been archived if there have been no financings, deals or product updates in BCIQ in the last five years, or the company is out of business.\nIf you believe a company has been archived in error, please contact us at \nsupport@biocentury.com\n.

Cat-H(AcquiredorMerged)

Historical deals and financings can be found by searching the organization's name in the BCIQ <DEALS> and <FINANCING> Modules.

Default (Company Type Blank)

CategoryHDefault (Company Type Blank)

NonBioPharma

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.

Cat-H(NonBioPharma)

Biopharma related deals can be found by searching the organization's name in the <DEALS> Module.\n

Gemma Frisius Fund

Venture Report: Curie.Bio’s fund; megarounds for Formation, EvolutionaryScale, BillionToOne

May 15 Quick Takes: VCs back Treg company Dualyx with €40M

AstriVax: thermostable, plug-and-play vaccines using plasmids

Aug. 25 Quick Takes: Radiopharma company Aktis tops off series A

Cartagenia N.V. completes venture financing

Complix completes venture financing

Complix raises EUR 12 million in series B

Arcarios completes venture financing

Complix: Scaffolds with a twist